3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
13
Urinary Bladder Neoplasms
11
Ovarian Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Neoplasm Metastasis
5
Colorectal Neoplasms
5
Cholangiocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Lymphoma, Large B-Cell, Diffuse
4
Fallopian Tube Neoplasms
4
Breast Neoplasms
4
Biliary Tract Neoplasms
4
Triple Negative Breast Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Rectal Neoplasms
2
Osteosarcoma
2
Lymphoma, Follicular
2
Gallbladder Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Bile Duct Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urologic Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Cyclophosphamide
9
fludarabine
5
zanubrutinib
3
Vincristine
3
Rituximab
3
Doxorubicin
3
pirtobrutinib
2
cemiplimab
2
Specimen Handling
2
Prednisone
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Dexamethasone
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
acalabrutinib
1
X-Rays
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Gemcitabine
×
30 days
×
Clear all
No trials found.